190 related articles for article (PubMed ID: 34366685)
1. Clinical characteristics and treatment outcomes of severe (ICU) COVID-19 patients in Saudi Arabia: A single centre study.
Alghamdi S
Saudi Pharm J; 2021 Oct; 29(10):1096-1101. PubMed ID: 34366685
[TBL] [Abstract][Full Text] [Related]
2. A Trial of Favipiravir and Hydroxychloroquine combination in Adults Hospitalized with moderate and severe Covid-19: A structured summary of a study protocol for a randomised controlled trial.
Bosaeed M; Mahmoud E; Hussein M; Alharbi A; Alsaedy A; Alothman A; Aljeraisy M; Alqahtani H; Nashabat M; Almutairi B; Almaghaslah M; Aldibasi O; AlJohani S; Bouchama A; Arabi Y; Alaskar A
Trials; 2020 Oct; 21(1):904. PubMed ID: 33129363
[TBL] [Abstract][Full Text] [Related]
3. Clinical features and prognostic factors of intensive and non-intensive 1014 COVID-19 patients: an experience cohort from Alahsa, Saudi Arabia.
Alhumaid S; Al Mutair A; Al Alawi Z; Al Salman K; Al Dossary N; Omar A; Alismail M; Al Ghazal AM; Jubarah MB; Al Shaikh H; Al Mahdi MM; Alsabati SY; Philip DK; Alyousef MY; Al Brahim AH; Al Athan MS; Alomran SA; Ahmed HS; Al-Shammari H; Elhazmi A; Rabaan AA; Al-Tawfiq JA; Al-Omari A
Eur J Med Res; 2021 May; 26(1):47. PubMed ID: 34030733
[TBL] [Abstract][Full Text] [Related]
4. Demographic Characteristics, Comorbidities, and Length of Stay of COVID-19 Patients Admitted Into Intensive Care Units in Saudi Arabia: A Nationwide Retrospective Study.
Al-Otaiby M; Almutairi KM; Vinluan JM; Al Seraihi A; Alonazi WB; Qahtani MH; Aljeri T; Alhumud MA; Alobaidi N; Alhurishi SA
Front Med (Lausanne); 2022; 9():893954. PubMed ID: 35911421
[TBL] [Abstract][Full Text] [Related]
5. Overview of clinical outcome and therapeutic effectiveness of Favipiravir in patients with COVID-19 admitted to intensive care unit, Riyadh, Saudi Arabia.
Mutair AA; Shamou J; Alhumaid S; Layqah L; Ahmed GY; Thoyaja K; Mohaini MA; Almahmoud S; Barry M; Khan A; Dhama K; Al-Jamea LH; Woodman A; Rabaan AA
J Infect Public Health; 2022 Apr; 15(4):389-394. PubMed ID: 35299062
[TBL] [Abstract][Full Text] [Related]
6. Clinical Efficacy of Hydroxychloroquine in Patients with COVID-19: Findings from an Observational Comparative Study in Saudi Arabia.
Alghamdi S; Barakat B; Berrou I; Alzahrani A; Haseeb A; Hammad MA; Anwar S; Sindi AAA; Almasmoum HA; Albanghali M
Antibiotics (Basel); 2021 Mar; 10(4):. PubMed ID: 33807320
[TBL] [Abstract][Full Text] [Related]
7. Comparing the impact of Hydroxychloroquine based regimens and standard treatment on COVID-19 patient outcomes: A retrospective cohort study.
Almazrou SH; Almalki ZS; Alanazi AS; Alqahtani AM; Alghamd SM
Saudi Pharm J; 2020 Dec; 28(12):1877-1882. PubMed ID: 33020690
[TBL] [Abstract][Full Text] [Related]
8. Predictors of Severity in Covid-19 Patients in Casablanca, Morocco.
El Aidaoui K; Haoudar A; Khalis M; Kantri A; Ziati J; El Ghanmi A; Bennis G; El Yamani K; Dini N; El Kettani C
Cureus; 2020 Sep; 12(9):e10716. PubMed ID: 33033687
[TBL] [Abstract][Full Text] [Related]
9. Clinical Characteristics and Treatment Outcomes of Mild to Moderate COVID-19 Patients at Tertiary Care Hospital, Al Baha, Saudi Arabia: A Single Centre Study.
Albanghali M; Alghamdi S; Alzahrani M; Barakat B; Haseeb A; Malik JA; Ahmed S; Anwar S
J Infect Public Health; 2022 Mar; 15(3):331-337. PubMed ID: 35151012
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics of non-intensive care unit COVID-19 patients in Saudi Arabia: A descriptive cross-sectional study.
Al-Omari A; Alhuqbani WN; Zaidi ARZ; Al-Subaie MF; AlHindi AM; Abogosh AK; Alrasheed AK; Alsharafi AA; Alhuqbani MN; Salih S; Alhedaithy MA; Abdulqawi R; Ismail AF; Alhumaid S; Hamdan N; Saad F; Olhaye FA; Eltahir TA; Alomari M; Alshehery M; Yassiri A; Al-Tawfiq JA; Al Mutair A
J Infect Public Health; 2020 Nov; 13(11):1639-1644. PubMed ID: 33004305
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics and outcome of ICU admitted MERS corona virus infected patients.
Halim AA; Alsayed B; Embarak S; Yaseen T; Dabbous S
Egypt J Chest Dis Tuberc; 2016 Jan; 65(1):81-87. PubMed ID: 32288128
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of and Outcomes in COVID-19 Critical Care Patients in the Qassim Region, Saudi Arabia.
Alharbi RM; Selim MA; Alowayed AA; Elhassan WH
Cureus; 2023 Nov; 15(11):e48323. PubMed ID: 38060713
[TBL] [Abstract][Full Text] [Related]
13. Epidemiological Characteristics and Outcomes Predictors for Intensive Care Unit COVID-19 Patients in Al-Madinah, Saudi Arabia. Retrospective Cohort Study.
Alhoufie ST; Mumena WA; Alsharif N; Makhdoom HM; Almutawif YA; Alfarouk KO; Alharbi MZ; Aljabri K; Aljifri A
Infect Drug Resist; 2023; 16():5573-5586. PubMed ID: 37645558
[TBL] [Abstract][Full Text] [Related]
14. Clinical, epidemiological, and laboratory characteristics of mild-to-moderate COVID-19 patients in Saudi Arabia: an observational cohort study.
Al Mutair A; Alhumaid S; Alhuqbani WN; Zaidi ARZ; Alkoraisi S; Al-Subaie MF; AlHindi AM; Abogosh AK; Alrasheed AK; Alsharafi AA; Alhuqbani MN; Alhowar NA; Salih S; Alhedaithy MA; Al-Tawfiq JA; Al-Shammari H; Abdulqawi R; Ismail AF; Hamdan N; Saad F; Olhaye FA; Eltahir TA; Rabaan AA; Al-Omari A
Eur J Med Res; 2020 Nov; 25(1):61. PubMed ID: 33239068
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics of COVID-19 in Saudi Arabia: A national retrospective study.
Alsofayan YM; Althunayyan SM; Khan AA; Hakawi AM; Assiri AM
J Infect Public Health; 2020 Jul; 13(7):920-925. PubMed ID: 32534945
[TBL] [Abstract][Full Text] [Related]
16. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
17. Comorbidities associated with risk of ICU admission in elderly patients with COVID-19: Data from academic hospital in Saudi Arabia.
Alsaad S; Addweesh A; Beyari M; Alkhateb M; Alswat A; Alshabnan A; Alsaad A; AlSaif H
Medicine (Baltimore); 2022 Sep; 101(39):e30799. PubMed ID: 36181092
[TBL] [Abstract][Full Text] [Related]
18. Clinical Characteristics and Predictors of 28-Day Mortality in 352 Critically Ill Patients with COVID-19: A Retrospective Study.
Alharthy A; Aletreby W; Faqihi F; Balhamar A; Alaklobi F; Alanezi K; Jaganathan P; Tamim H; Alqahtani SA; Karakitsos D; Memish ZA
J Epidemiol Glob Health; 2021 Mar; 11(1):98-104. PubMed ID: 33095982
[TBL] [Abstract][Full Text] [Related]
19. Clinical features, treatments and outcomes of influenza A (H1N1) 2009 among the hospitalized patients in the clinic for infectious diseases in Novi Sad.
Canak G; Kovacević N; Vukadinov J; Turkulov V; Sević S; Doder R; Somborac S; Potkonjak A
Vojnosanit Pregl; 2013 Feb; 70(2):155-62. PubMed ID: 23607182
[TBL] [Abstract][Full Text] [Related]
20. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.
Valk SJ; Piechotta V; Chai KL; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
Cochrane Database Syst Rev; 2020 May; 5(5):CD013600. PubMed ID: 32406927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
